Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification
Poston WS, Reeves RS, Haddock CK, Stormer S, Balasubramanyam A, Satterwhite O, Taylor JE, Foreyt JP
International Journal of Obesity and Related Metabolic Disorders 2003 Dec;27(12):1486-1493
clinical trial
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVE: To evaluate the effectiveness of a culturally appropriate lifestyle intervention combined with orlistat in producing weight loss with obese Mexican-American women. SUBJECTS: Mexican-American women (n = 108), aged 21 to 65 y, with a body mass index (BMI) >= 27 kg/m2 were randomized to 1 y of treatment with orlistat and a culturally tailored lifestyle modification intervention (OLM; n = 56) or a wait-list control group (WLC; n = 52). DESIGN: A randomized, controlled, open-label 12-month study. Orlistat was dosed at 120 mg, three times per day. The OLM intervention included behavior modification, a low-fat (<= 30% of total daily calories) diet, and moderate physical activity (>= 150 min/week). MEASUREMENT: Primary outcomes included changes in body weight (kg), BMI, waist circumference, blood pressure, glucose, and lipids. RESULTS: A total of 72 (37 OLM, 35 WLC) and 66 participants (32 OLM, 34 WLC) completed the 6- and 12-month follow-ups, respectively. Repeated-measures ANOVA demonstrated a significant time x treatment interaction (Wilks' lambda = 12.61; p < 0.001), indicating that OLM-treated patients achieved significant weight loss relative to the WLC group during the study (mean percentage weight loss +/- SEM; -8.1% +/- 1.2 versus -1.6% +/- 0.7 at 6 months and -8.8% +/- 1.5 versus -0.2% +/- 1.0 at 12 months, respectively). OLM-treated patients also experienced significant reductions in waist circumference, low-density-lipoprotein, and total cholesterol. CONCLUSIONS: This study demonstrates the effectiveness of an intervention combining orlistat and lifestyle modification with Mexican-American women, a population with substantial risk for obesity.

Full text (sometimes free) may be available at these link(s):      help